Main Article Content
Abstract
Keywords
Article Details
-
Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:
Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
You are free to :
Share ” copy and redistribute the material in any medium or format.
Adapt ” remix, transform, and build upon the material.
References
- Askarzadeh K, People F, Moztarzadeh F (2005). Fabrication and characterization of a porous compo-site implant based on gelatin and hydroxyapatite for bone tissue engineering. Iranian Polymer Journal 14, 511-520
- Azami M, Tavakol S, Samadikuchaksaraei A, Hashjin SM, Baheiraei N, Kamali M, Nourani MR (2012). A porous hydroxyapatite/gelatin nanocomposite implant for bone tissue repair: In vitro and in vivo evaluation. Journal of Biomaterial Science 23, 2353-2368
- Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A (2008). Alendronate - hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast - like cells. J. Biomaterials 29, 790-796
- Brunner & Suddarth (1997). Brunner and Suddarth's Journal of Medical-Surgical Nursing . 7th Ed. 6-15.
- Budiatin Aniek Setiya, et al (2013). Gentamicin release from bovin-hydroxy-apatite-gelatin implant as a drug and bone filling delivery system. Indonesian Journal of Pharmacy and Pharmaceutical Sciences 1, 10-11
- Budiatin AS, Zainuddin M, Khotib J (2014). Biocompatable composite as gentamicin delivery system for osteomyelitis and bone regeneration. International Journal of Pharmacy and Pharmaceutical Sciences 6, 223-226
- Capra P, Dorati R, Colonna C, Giovanna B, Pavanetto, F, Genta I, Conti B (2011). A preliminary study on the morphological and release properties of hydroxyapa-tite-alendronate composite materials. Journal of Microencapsulation 28, 395-405
- Cattalini JP, Boccaccini AR, Habil Dr.-Ing, Lucangioli S, Mourino V (2012). Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants. Tissue Engineering Part B 18, 5-8
- Chang J, Lin K (2015). Structure and properties of hydroxyapatite for biomedical applications. Hap for Biomedical Applications, 3-19
- Chao SC, Wang MJ, Pai NS, Yen SK (2015). Preparation and characterization of gelatin-hydroxyapatite composite microspheres for hard tissue repair. Materials Science and Engineering C 57, 113-122
- Chen G, Deng C, Li YP (2012). TGF-β and BMP signaling in osteoblast differentiation and bone formation. International Journal of Biological Sciences 8, 272-288
- Cottrell JA, Vales FM, Schachter D, Wadsworth S, Gundlapalli R, Kapadia R, O'Connor JP (2010). Osteogenic activity of locally applied small molecule drugs in a rat femur defect model. Journal of Biomedicine and Biotechnology 597641, 1-2
- Einhorn TA (2010). Can an anti-fracture agent heal fractures?. Clinical Cases in Minerals and Bone Metabolism 6, 251-253
- Einhorn TA, Gerstenfeld LC (2014). Fracture healing: Mechanism and interventions. Nature Reviews Rheumatology, 355-337
- Ellis EG, Kathleen B (2007). The role of alkaline phosphatase in mineralization. Curr Opin Orthop 18, 444-448
- Ferdiansyah, Rushadi D, Rantam FA, Aulani'am (2010). Regeneration of massive bone defect with bovine hydroxyapatite as mesenchymal stem cells' implants 13, 179-195
- Fischer AH, Jacobson KA, Rose J, Zeller R (2008). Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harbor Protocols 3, 4986-4988
- Goes P, Melo MI, Dutra SC, Lima SPA, Lima V (2012). Effect of alendronate on bone - specific alkaline phosphatase on periodontal bone loss in rats. Archives of Oral Biology 57, 1537-1274
- Greenblatt MB, Tsi JN, Wein, MN (2017). Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clinical Chemistry 63, 464-474
- Guyton AC, Hall JE (2007). Medical physiology textbook. 9th Ed. Jakarta, EGC, p 6-7
- Hikmawati D, Maulida HN, Putra AP, Budiatin AS and Syahrom A (2019). Synthesis and characterization of nanohydroxyapatite-gelatin composite with streptomy-cin as antituberculosis injectable bone substitute. International Journal of Biomaterials 2019
- Kalfas IH (2001). Principles of bone healing. Neurosurg Focus 10, 7-10
- Kim, HW, Knowles, JC, Kim HE (2004). Hydroxyapatite and gelatin composite foams processed via novel freeze-drying and crosslinking for use as temporary hard tissue implants. Journal of Biomedical Materials Research - Part A 72, 136-145
- Kusrini E, Sontang M (2012). Characterization of X-ray diffraction and electron spin resonance: Effects of sintering time and temperature on bovine hydroxyapatite. Rad Physical and Chem, 118-125
- Marsell R, Einhorn TA (2011). The biology of fracture healing. Injury 42, 551-555
- Maulida HN, Hikmawati D, Budiatin AS (2015). Injectable bone substitute paste based on hydroxyapatite, gelatin and streptomycin for spinal tuberculosis. The Spine Journal 4, 4-7
- Narbat KM, Orang F, Hashtjin SM, Goudarzi A (2006). Fabrication of porous hydroxyapatite-gelatin composite implans for bone tissue engineering. Iranian Biomed J. 10, 215-223
- Ning B, Zhao Y, Buza III JA, Li W, Wang W, Jia T (2017). Surgically-induced mouse models in the study of bone regeneration: Current models and future directions. Molecular Medicine Reports 15, 1017-1023
- Pagani F, Francucci CM, Moro L (2005). Markers of bone turnover: Biochemical and clinical perspectives J Endocrinol Invest 28, 8-13
- Raggatt LJ, Partridge NC (2010). Cellular and molecular mechanism of bone remodeling. Journal of Biological Chemistry 285, 25103-25108
- Ramirez-Fernandez MP, Calvo-Guirado JL, Delgado-Ruiz RA, Mate-Sanchez del Val JE, Gomez-Moreno G, Guardia J (2011). Experimental model of bone response to xenografts of bovine origin (Endone®): a radiological and histomorphometric study. Clin.Oral Impl.Res 22, 727-734
- Schlickewei WC, Laaff G, Andresen A, Klatte OT, Rueger Mj, Ruesing J, Epple M, Lehmann W (2015). Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite - an animal model. Journal of Orthopedic Surgery and Research 10, 116
- Seibel MJ (2000). Molecular markers of bone turnover: biochemical, technical and analytical aspects. International Osteoporosis Foundation and National Osteoporosis Foundation 6, S18-29
- Sihombing D, Nursiswati, Prawesti A (2012). Overview of foot care and sensory sensation of feet in patients with type 2 diabetes mellitus in the dm polyclinic hospital
- Silva RF, Sasso GRD, Cerri ES, Simoes MJ, Cerri PS (2015). Review article. Biology of bone tissue: structure, function, and factors that influence bone cells. BioMed Research International 2015, 1-17
- Sousa CP, Dias IR, Pena ML, Camassa JA, Lourenco PJ, Judas FM, Gomes ME, Reis RL (2015). Bone turnover markers for early detection of fracture healing disturbances. Anais da Academia Brasileira de Ciencias 87, 1049-1061
References
Askarzadeh K, People F, Moztarzadeh F (2005). Fabrication and characterization of a porous compo-site implant based on gelatin and hydroxyapatite for bone tissue engineering. Iranian Polymer Journal 14, 511-520
Azami M, Tavakol S, Samadikuchaksaraei A, Hashjin SM, Baheiraei N, Kamali M, Nourani MR (2012). A porous hydroxyapatite/gelatin nanocomposite implant for bone tissue repair: In vitro and in vivo evaluation. Journal of Biomaterial Science 23, 2353-2368
Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A (2008). Alendronate - hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast - like cells. J. Biomaterials 29, 790-796
Brunner & Suddarth (1997). Brunner and Suddarth's Journal of Medical-Surgical Nursing . 7th Ed. 6-15.
Budiatin Aniek Setiya, et al (2013). Gentamicin release from bovin-hydroxy-apatite-gelatin implant as a drug and bone filling delivery system. Indonesian Journal of Pharmacy and Pharmaceutical Sciences 1, 10-11
Budiatin AS, Zainuddin M, Khotib J (2014). Biocompatable composite as gentamicin delivery system for osteomyelitis and bone regeneration. International Journal of Pharmacy and Pharmaceutical Sciences 6, 223-226
Capra P, Dorati R, Colonna C, Giovanna B, Pavanetto, F, Genta I, Conti B (2011). A preliminary study on the morphological and release properties of hydroxyapa-tite-alendronate composite materials. Journal of Microencapsulation 28, 395-405
Cattalini JP, Boccaccini AR, Habil Dr.-Ing, Lucangioli S, Mourino V (2012). Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants. Tissue Engineering Part B 18, 5-8
Chang J, Lin K (2015). Structure and properties of hydroxyapatite for biomedical applications. Hap for Biomedical Applications, 3-19
Chao SC, Wang MJ, Pai NS, Yen SK (2015). Preparation and characterization of gelatin-hydroxyapatite composite microspheres for hard tissue repair. Materials Science and Engineering C 57, 113-122
Chen G, Deng C, Li YP (2012). TGF-β and BMP signaling in osteoblast differentiation and bone formation. International Journal of Biological Sciences 8, 272-288
Cottrell JA, Vales FM, Schachter D, Wadsworth S, Gundlapalli R, Kapadia R, O'Connor JP (2010). Osteogenic activity of locally applied small molecule drugs in a rat femur defect model. Journal of Biomedicine and Biotechnology 597641, 1-2
Einhorn TA (2010). Can an anti-fracture agent heal fractures?. Clinical Cases in Minerals and Bone Metabolism 6, 251-253
Einhorn TA, Gerstenfeld LC (2014). Fracture healing: Mechanism and interventions. Nature Reviews Rheumatology, 355-337
Ellis EG, Kathleen B (2007). The role of alkaline phosphatase in mineralization. Curr Opin Orthop 18, 444-448
Ferdiansyah, Rushadi D, Rantam FA, Aulani'am (2010). Regeneration of massive bone defect with bovine hydroxyapatite as mesenchymal stem cells' implants 13, 179-195
Fischer AH, Jacobson KA, Rose J, Zeller R (2008). Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harbor Protocols 3, 4986-4988
Goes P, Melo MI, Dutra SC, Lima SPA, Lima V (2012). Effect of alendronate on bone - specific alkaline phosphatase on periodontal bone loss in rats. Archives of Oral Biology 57, 1537-1274
Greenblatt MB, Tsi JN, Wein, MN (2017). Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clinical Chemistry 63, 464-474
Guyton AC, Hall JE (2007). Medical physiology textbook. 9th Ed. Jakarta, EGC, p 6-7
Hikmawati D, Maulida HN, Putra AP, Budiatin AS and Syahrom A (2019). Synthesis and characterization of nanohydroxyapatite-gelatin composite with streptomy-cin as antituberculosis injectable bone substitute. International Journal of Biomaterials 2019
Kalfas IH (2001). Principles of bone healing. Neurosurg Focus 10, 7-10
Kim, HW, Knowles, JC, Kim HE (2004). Hydroxyapatite and gelatin composite foams processed via novel freeze-drying and crosslinking for use as temporary hard tissue implants. Journal of Biomedical Materials Research - Part A 72, 136-145
Kusrini E, Sontang M (2012). Characterization of X-ray diffraction and electron spin resonance: Effects of sintering time and temperature on bovine hydroxyapatite. Rad Physical and Chem, 118-125
Marsell R, Einhorn TA (2011). The biology of fracture healing. Injury 42, 551-555
Maulida HN, Hikmawati D, Budiatin AS (2015). Injectable bone substitute paste based on hydroxyapatite, gelatin and streptomycin for spinal tuberculosis. The Spine Journal 4, 4-7
Narbat KM, Orang F, Hashtjin SM, Goudarzi A (2006). Fabrication of porous hydroxyapatite-gelatin composite implans for bone tissue engineering. Iranian Biomed J. 10, 215-223
Ning B, Zhao Y, Buza III JA, Li W, Wang W, Jia T (2017). Surgically-induced mouse models in the study of bone regeneration: Current models and future directions. Molecular Medicine Reports 15, 1017-1023
Pagani F, Francucci CM, Moro L (2005). Markers of bone turnover: Biochemical and clinical perspectives J Endocrinol Invest 28, 8-13
Raggatt LJ, Partridge NC (2010). Cellular and molecular mechanism of bone remodeling. Journal of Biological Chemistry 285, 25103-25108
Ramirez-Fernandez MP, Calvo-Guirado JL, Delgado-Ruiz RA, Mate-Sanchez del Val JE, Gomez-Moreno G, Guardia J (2011). Experimental model of bone response to xenografts of bovine origin (Endone®): a radiological and histomorphometric study. Clin.Oral Impl.Res 22, 727-734
Schlickewei WC, Laaff G, Andresen A, Klatte OT, Rueger Mj, Ruesing J, Epple M, Lehmann W (2015). Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite - an animal model. Journal of Orthopedic Surgery and Research 10, 116
Seibel MJ (2000). Molecular markers of bone turnover: biochemical, technical and analytical aspects. International Osteoporosis Foundation and National Osteoporosis Foundation 6, S18-29
Sihombing D, Nursiswati, Prawesti A (2012). Overview of foot care and sensory sensation of feet in patients with type 2 diabetes mellitus in the dm polyclinic hospital
Silva RF, Sasso GRD, Cerri ES, Simoes MJ, Cerri PS (2015). Review article. Biology of bone tissue: structure, function, and factors that influence bone cells. BioMed Research International 2015, 1-17
Sousa CP, Dias IR, Pena ML, Camassa JA, Lourenco PJ, Judas FM, Gomes ME, Reis RL (2015). Bone turnover markers for early detection of fracture healing disturbances. Anais da Academia Brasileira de Ciencias 87, 1049-1061